A serological assay for the detection of Human IgG antibodies against the SARS-CoV-2 spike glycoprotein RBD in human plasma and serum
Features
  • Qualitative assay for detection of IgG antibodies against the SARS-CoV-2 Spike Glycoprotein RBD
  • Validated in plasma and serum from COVID-19-positive and -negative individuals and individuals vaccinated against SARS-CoV-2
  • Rapid assay; get results in < 3 hours
  • Run up to 44 samples in duplicate
  • Plate-based colorimetric readout (450 nm)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Anti-SARS-CoV-2 Spike Glycoprotein RBD IgG (human) ELISA Kit

Item No. 502110

Kit Booklet (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein Receptor Binding Domain IgG
Origin
Animal/Bovine, Animal/Mouse
Shipping & Storage Information
Storage
-20°C
Shipping
in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    96 strip wells

    $467

    Add
    Bioanalysis & Assay Development Services
    Your Vision. Our Expertise.
    • Bioanalysis and compound screening using Cayman or qualified commercial assay kits
    • Development and qualification of fit-for-purpose assays in a variety of formats and platforms
    • Experienced scientists dedicated to developing the best strategy for your project
    LEARN MORE
    Product Description

    Cayman’s Anti-SARS-CoV-2 Spike Glycoprotein RBD IgG (human) ELISA Kit is an enzyme-linked immunosorbent assay that can be used for the qualitative assessment of the presence of antibodies against the SARS-CoV-2 spike glycoprotein RBD in human plasma and serum. In general, while PCR positivity indicates the presence of viral antigens, this serological assay indicates the presence of IgG antibodies against the SARS-CoV-2 spike glycoprotein RBD, which occurs in the weeks following SARS-CoV-2 infection. The IgG response measured in this kit does not differentiate neutralizing antibodies, which specifically interrupt the interaction between the spike glycoprotein RBD and the ACE2 receptor on the host cell, from non-neutralizing antibodies that bind to the RBD. A positive control is included in this kit to provide a cut-off for seropositivity.

    Needed but not supplied: Please download the kit booklet to verify if UltraPure Water (Milli-Q or equivalent) or any other components are needed for this assay.

    WARNING This product is not for human or veterinary use.